Dairy farm equipment provider Paul Mueller's Q3 net sales dip

Paul Mueller

24/10/2025 22:40

Overview

Paul Mueller Q3 net sales fell slightly compared to the same period last year

Net income for Q3 declined due to challenges in pharmaceutical projects

Company announces tender offer at $485 per share ending November 21, 2025

Result Drivers

PHARMACEUTICAL PROJECT CHALLENGES - Co faced difficulties in fabrication tasks for two large pharmaceutical jobs, impacting Q3 earnings

BACKLOG INCREASE - U.S. backlog rose significantly, driven by pharmaceutical clients in the Industrial Equipment segment

EUROPEAN OPERATIONS - European backlog nearly doubled, indicating growth in that region

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
9M Sales
$192.85 mln
9M Net Income
$21.43 mln
9M Gross Profit
$61.71 mln
9M Operating Income
$26.54 mln


Press Release: ID:nGNX6pK9MX

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)